Beta Bionics integrates with Libre 3 Plus
By HME News Staff
Updated 11:25 AM CDT, Thu October 31, 2024
IRVINE, Calif. – Beta Bionics has launched the integration of its flagship iLet Bionic Pancreas with Abbott’s FreeStyle Libre 3 Plus sensor. The iLet Bionic Pancreas is an autonomous insulin delivery system that streamlines diabetes management and is the first insulin delivery system in the United States to connect to Abbott’s FreeStyle Libre 3 Plus sensor, whose readings every minute will help iLet calculate insulin doses. “Beta Bionics continues to move at lightning speed to bring these enhancements to our userbase,” said Sean Saint, CEO of Beta Bionics. “With our recent launch of the Bionic Circle remote monitoring app, our latest updates to the iLet app, and today’s launch of the iLet integration with Abbott’s FreeStyle Libre 3 Plus sensor, we are focused on providing major product enhancements to make diabetes management even easier for our users and their families.” With both Beta Bionics’ and FreeStyle Libre’s ability to sell products through the pharmacy channel, users of the integrated platform can benefit from the ease of obtaining supplies with an innovative pay-as-you-go model. The iLet and FreeStyle Libre 3 Plus sensor are also available through durable medical equipment providers. By simply updating the iLet app and software, iLet users will have a choice of iCGMs (FreeStyle Libre 3 Plus sensor or Dexcom CGMs) when they set up a new sensor.
Comments